BiotechTubeBiotechTube
Home/Longeveron/Stephen H. Willard
SH

Stephen H. Willard

Chief Executive Officer

Longeveron

Therapeutic Areas

AgingCardiologyNeurologyRare Disease

Longeveron Pipeline

DrugIndicationPhase
Laromestrocel (Lomecel-B™)Alzheimer’s DiseasePhase 2

Leadership Team at Longeveron

TP
Than Powell
Interim Chief Executive Officer, Vice President and Chief Business Officer
DJ
Dr. Joshua Hare
Co-founder, Chief Science Officer and Chairman
SK
Sunjay Kaushal, MD, PhD
Key Opinion Leader (Featured in KOL Event)
RK
Ram Kumar Subramanyan, MD, PhD
Key Opinion Leader (Featured in KOL Event)
View full Longeveron profile